L. Bubendorf, A. Schöpfer, and U. Wagner, Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients, Human Pathology, vol.31, issue.5, pp.578-583, 2000.
DOI : 10.1053/hp.2000.6698

K. Roehl, M. Han, C. Ramos, J. Antenor, and W. Catalona, CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS, The Journal of Urology, vol.172, issue.3, pp.910-914, 2004.
DOI : 10.1097/01.ju.0000134888.22332.bb

G. Hull, F. Rabbani, F. Abbas, T. Wheeler, M. Kattan et al., CANCER CONTROL WITH RADICAL PROSTATECTOMY ALONE IN 1,000 CONSECUTIVE PATIENTS, The Journal of Urology, vol.167, issue.2, pp.528-534, 2002.
DOI : 10.1016/S0022-5347(01)69079-7

F. Daneshgari and E. Crawford, Endocrine therapy of advanced carcinoma of the prostate, Cancer, vol.146, issue.3, pp.1089-1097, 1993.
DOI : 10.1002/1097-0142(19930201)71:3+<1089::AID-CNCR2820711431>3.0.CO;2-H

J. Eymard, S. Oudard, and G. Gravis, Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study, BJU International, vol.55, issue.18, pp.974-978, 2010.
DOI : 10.1111/j.1464-410X.2010.09296.x

S. Bigler, R. Deering, and M. Brawer, Comparison of microscopic vascularity in benign and malignant prostate tissue, Human Pathology, vol.24, issue.2, pp.220-226, 1993.
DOI : 10.1016/0046-8177(93)90304-Y

D. Stefanou, A. Batistatou, S. Kamina, E. Arkoumani, D. Papachristou et al., Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer, In Vivo, vol.18, pp.155-160, 2004.

R. Siegel, D. Naishadham, and A. Jemal, Cancer statistics, 2013, CA: A Cancer Journal for Clinicians, vol.287, issue.suppl 5, pp.11-30, 2013.
DOI : 10.3322/caac.21166

G. Haas, N. Delongchamps, R. Jones, V. Chandan, A. Serio et al., Needle Biopsies on Autopsy Prostates: Sensitivity of Cancer Detection Based on True Prevalence, JNCI Journal of the National Cancer Institute, vol.99, issue.19, pp.1484-1489, 2007.
DOI : 10.1093/jnci/djm153

T. Stamey, C. Yemoto, J. Mcneal, B. Sigal, and I. Johnstone, PROSTATE CANCER IS HIGHLY PREDICTABLE: A PROGNOSTIC EQUATION BASED ON ALL MORPHOLOGICAL VARIABLES IN RADICAL PROSTATECTOMY SPECIMENS, The Journal of Urology, vol.163, issue.4, pp.1155-1160, 2000.
DOI : 10.1016/S0022-5347(05)67713-0

R. Gulati, E. Wever, A. Tsodikov, D. Penson, L. Inoue et al., What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, American Society of Preventive Oncology, vol.20, issue.5, pp.740-750, 2011.

O. Pertz, L. Hodgson, R. Klemke, and K. Hahn, Spatiotemporal dynamics of RhoA activity in migrating cells, Nature, vol.406, issue.7087, pp.1069-1072, 2006.
DOI : 10.1038/nature04665

M. Machacek, L. Hodgson, C. Welch, H. Elliott, O. Pertz et al., Coordination of Rho GTPase activities during cell protrusion, Nature, vol.406, issue.7260, pp.99-10310, 1038.
DOI : 10.1038/nature08242

K. Kurokawa and M. Matsuda, Localized RhoA Activation as a Requirement for the Induction of Membrane Ruffling, Molecular Biology of the Cell, vol.16, issue.9, pp.4294-4303, 2005.
DOI : 10.1091/mbc.E04-12-1076

M. Sakurai-yageta, C. Recchi, L. Dez, G. Sibarita, J. Daviet et al., The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA, The Journal of Cell Biology, vol.15, issue.6, pp.985-998, 2008.
DOI : 10.1097/01.LAB.0000041713.74852.2A

K. Hotary, X. Li, E. Allen, S. Stevens, and S. Weiss, A cancer cell metalloprotease triad regulates the basement membrane transmigration program, Genes & Development, vol.20, issue.19, pp.2673-2686, 2006.
DOI : 10.1101/gad.1451806

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1578694

S. Berton, B. Belletti, K. Wolf, V. Canzonieri, F. Lovat et al., The Tumor Suppressor Functions of p27kip1 Include Control of the Mesenchymal/Amoeboid Transition, Molecular and Cellular Biology, vol.29, issue.18, pp.5031-504500144, 2009.
DOI : 10.1128/MCB.00144-09

A. Horiuchi, T. Imai, C. Wang, S. Ohira, Y. Feng et al., Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma investigation, Laboratory, vol.83, issue.6, pp.861-870, 2003.

F. Modolo, M. Biz, S. De-sousa, F. Rde, L. et al., Immunohistochemical expression of Rho GTPases in ameloblastomas, Journal of Oral Pathology & Medicine, vol.88, issue.5, pp.400-407, 2012.
DOI : 10.1111/j.1600-0714.2011.01108.x

G. Fritz, C. Brachetti, F. Bahlmann, M. Schmidt, and B. Kaina, Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters, British Journal of Cancer, vol.59, issue.6, pp.635-644, 2002.
DOI : 10.1038/sj.bjc.6600510

A. Struckhoff, M. Rana, and R. Worthylake, RhoA can lead the way in tumor cell invasion and metastasis, Frontiers in Bioscience, vol.16, issue.1, pp.1915-1926, 2011.
DOI : 10.2741/3830

L. Schmidt, K. Duncan, N. Yadav, K. Regan, A. Verone et al., RhoA as a Mediator of Clinically Relevant Androgen Action in Prostate Cancer Cells, Molecular Endocrinology, vol.26, issue.5, pp.716-735, 2012.
DOI : 10.1210/me.2011-1130

S. Etienne-manneville and A. Hall, Rho GTPases in cell biology, Nature, vol.92, issue.6916, pp.629-63510, 1038.
DOI : 10.1074/jbc.M108297200

J. Pille, C. Denoyelle, J. Varet, J. Bertrand, J. Soria et al., Anti-RhoA and Anti-RhoC siRNAs Inhibit the Proliferation and Invasiveness of MDA-MB-231 Breast Cancer Cells in Vitro and in Vivo, Molecular Therapy, vol.11, issue.2, pp.267-274, 2005.
DOI : 10.1016/j.ymthe.2004.08.029

H. Sun, S. Tong, J. He, Q. Wang, L. Zou et al., RhoA and RhoC -siRNA inhibit the proliferation and invasiveness activity of human gastric carcinoma by Rho/PI3K/Akt pathway, World Journal of Gastroenterology, vol.13, issue.25, pp.133517-3522, 2007.
DOI : 10.3748/wjg.v13.i25.3517

J. Hodge, J. Bub, S. Kaul, A. Kajdacsy-balla, and P. Lindholm, Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion, Cancer research, vol.63, issue.6, pp.1359-1364, 2003.

R. Zheng, A. Iwase, R. Shen, O. Goodman, J. Sugimoto et al., Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase, Oncogene, vol.389, issue.44, pp.5942-5952, 2006.
DOI : 10.1074/jbc.273.27.16782

R. Loberg, K. Tantivejkul, M. Craig, C. Neeley, and K. Pienta, PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells, Journal of Cellular Biochemistry, vol.20, issue.5, pp.1292-1300, 2007.
DOI : 10.1002/jcb.21252

X. Chen, J. Corbin, G. Tipton, L. Yang, A. Asch et al., The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1843, issue.6, pp.1216-1224, 2014.
DOI : 10.1016/j.bbamcr.2014.03.005

S. Yamamura, S. Saini, S. Majid, H. Hirata, K. Ueno et al., MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells, PLoS ONE, vol.9, issue.1, 2012.
DOI : 10.1371/journal.pone.0029722.s005

M. Grandoch, A. Rose, M. Ter-braak, V. Jendrossek, H. Rubben et al., Epac inhibits migration and proliferation of human prostate carcinoma cells, British Journal of Cancer, vol.63, issue.12, pp.2038-2042, 2009.
DOI : 10.1152/ajpheart.01317.2007

C. Zhou, M. Ling, K. Lee, T. Man, K. Wang et al., FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase, Cancer Letters, vol.233, issue.1, pp.36-4729, 1210.
DOI : 10.1016/j.canlet.2005.02.039

F. Cianchi, S. Cuzzocrea, M. Vinci, L. Messerini, C. Comin et al., Heterogeneous expression of cyclooxygenase-2 and inducible nitric oxide synthase within colorectal tumors: correlation with tumor angiogenesis. Digestive and liver disease : official journal of the Italian Society of CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers, Gastroenterology and the Italian Association for the Study of the Liver Delongchamps NB World journal of urology, vol.42, issue.1, pp.20-27, 2010.

S. Gasman, S. Chasserot-golaz, P. Hubert, D. Aunis, and M. Bader, Identification of a Potential Effector Pathway for the Trimeric Go Protein Associated with Secretory Granules. Go STIMULATES A GRANULE-BOUND PHOSPHATIDYLINOSITOL 4-KINASE BY ACTIVATING RhoA IN CHROMAFFIN CELLS, Journal of Biological Chemistry, vol.273, issue.27, pp.16913-16920, 1998.
DOI : 10.1074/jbc.273.27.16913

C. Frantz, T. Coppola, and R. Regazzi, Involvement of Rho GTPases and their effectors in the secretory process of PC12 cellsThe incidence of malignancy in Urban Shanghai, Tumor, vol.273, issue.32, pp.119-126, 2002.

Y. Akagi, W. Liu, B. Zebrowski, K. Xie, and L. M. Ellis, Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I, Cancer Res, vol.58, issue.17, pp.4008-4014, 1998.

A. S. Alberts, N. Bouquin, L. H. Johnston, and R. Treisman, Analysis of RhoA-binding Proteins Reveals an Interaction Domain Conserved in Heterotrimeric G Protein ?? Subunits and the Yeast Response Regulator Protein Skn7, Journal of Biological Chemistry, vol.273, issue.15, pp.8616-8622, 1998.
DOI : 10.1074/jbc.273.15.8616

S. Alexander, G. E. Koehl, M. Hirschberg, E. K. Geissler, and P. Friedl, Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model, Histochemistry and Cell Biology, vol.64, issue.6, pp.1147-1154, 2008.
DOI : 10.1007/s00418-008-0529-1

M. Amano, K. Chihara, N. Nakamura, T. Kaneko, Y. Matsuura et al., The COOH Terminus of Rho-kinase Negatively Regulates Rho-kinase Activity, Journal of Biological Chemistry, vol.274, issue.45, pp.32418-32424, 1999.
DOI : 10.1074/jbc.274.45.32418

F. Pinsky, P. C. Prorok, J. K. Gohagan, and C. D. Berg, Mortality results from a randomized prostate-cancer screening trial, N Engl J Med, vol.360, issue.13, pp.1310-1319, 2009.

A. Bagnato and L. Rosanò, The endothelin axis in cancer, The International Journal of Biochemistry & Cell Biology, vol.40, issue.8, pp.1443-1451, 2008.
DOI : 10.1016/j.biocel.2008.01.022

G. Bergers and D. Hanahan, Modes of resistance to anti-angiogenic therapy, Nature Reviews Cancer, vol.25, issue.8, pp.592-603, 2008.
DOI : 10.1038/nrc2442

S. Berton, B. Belletti, K. Wolf, V. Canzonieri, F. Lovat et al., The Tumor Suppressor Functions of p27kip1 Include Control of the Mesenchymal/Amoeboid Transition, Molecular and Cellular Biology, vol.29, issue.18, pp.5031-5045, 2009.
DOI : 10.1128/MCB.00144-09

G. Berx and F. Van-roy, Involvement of Members of the Cadherin Superfamily in Cancer, Cold Spring Harbor Perspectives in Biology, vol.1, issue.6, p.3129, 2009.
DOI : 10.1101/cshperspect.a003129

S. A. Bigler, R. E. Deering, and M. K. Brawer, Comparison of microscopic vascularity in benign and malignant prostate tissue, Human Pathology, vol.24, issue.2, pp.220-226, 1993.
DOI : 10.1016/0046-8177(93)90304-Y

W. C. Black and H. G. Welch, Advances in Diagnostic Imaging and Overestimations of Disease Prevalence and the Benefits of Therapy, New England Journal of Medicine, vol.328, issue.17, pp.1237-1243, 1993.
DOI : 10.1056/NEJM199304293281706

D. Bobak, J. Moorman, A. Guanzon, L. Gilmer, and C. Hahn, Inactivation of the small GTPase Rho disrupts cellular attachment and induces adhesion-dependent and adhesion-independent apoptosis, Oncogene, vol.15, issue.18, pp.2179-2189, 1997.
DOI : 10.1038/sj.onc.1201396

R. A. Bok, S. Halabi, D. T. Fei, C. R. Rodriquez, D. F. Hayes et al., Vascular endothelial growth factor and basic fibroblast growth factor urine levels as predictors of outcome in hormone-refractory prostate cancer patients: a cancer and leukemia group B study, Cancer Res, vol.61, issue.6, pp.2533-2536, 2001.

M. Borre, B. V. Offersen, B. Nerstrom, and J. Overgaard, Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting, British Journal of Cancer, vol.78, issue.7, pp.940-944, 1998.
DOI : 10.1038/bjc.1998.605

H. R. Bourne, D. A. Sanders, and F. Mccormick, The GTPase superfamily: a conserved switch for diverse cell functions, Nature, vol.348, issue.6297, pp.125-132, 1990.
DOI : 10.1038/348125a0

H. R. Bourne, D. A. Sanders, and F. Mccormick, The GTPase superfamily: conserved structure and molecular mechanism, Nature, vol.349, issue.6305, pp.117-127, 1991.
DOI : 10.1038/349117a0

T. Brabletz, F. Hlubek, S. Spaderna, O. Schmalhofer, E. Hiendlmeyer et al., Invasion and Metastasis in Colorectal Cancer: Epithelial-Mesenchymal Transition, Mesenchymal-Epithelial Transition, Stem Cells and ??-Catenin, Cells Tissues Organs, vol.179, issue.1-2, pp.56-65, 2005.
DOI : 10.1159/000084509

B. A. Bryan, E. Dennstedt, D. C. Mitchell, T. E. Walshe, K. Noma et al., RhoA/ROCK signaling is essential for multiple aspects of VEGF-mediated angiogenesis, The FASEB Journal, vol.24, issue.9, pp.3186-3195, 2010.
DOI : 10.1096/fj.09-145102

Q. Bu, H. M. Tang, J. Tan, X. Hu, and D. W. Wang, Expression of RhoC and ROCK-1 and their effects on MAPK and Akt proteins in prostate carcinoma, Zhonghua Zhong Liu Za Zhi, vol.33, issue.3, pp.202-206, 2011.

L. Bubendorf, A. Schöpfer, U. Wagner, G. Sauter, H. Moch et al., Metastatic patterns of prostate cancer: An autopsy study of 1,589 patients, Human Pathology, vol.31, issue.5, pp.578-583, 2000.
DOI : 10.1053/hp.2000.6698

X. R. Bustelo, V. Sauzeau, and I. M. Berenjeno, GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo, BioEssays, vol.20, issue.4, pp.356-370, 2007.
DOI : 10.1002/bies.20558

A. M. Byrne, D. J. Bouchier-hayes, and J. H. Harmey, Angiogenic and cell survival functions of Vascular Endothelial Growth Factor (VEGF), Journal of Cellular and Molecular Medicine, vol.8, issue.4, pp.777-794, 2005.
DOI : 10.1073/pnas.2135406100

U. Cavallaro and G. Christofori, Cell adhesion and signalling by cadherins and Ig-CAMs in cancer, Nature Reviews Cancer, vol.2, issue.2, pp.118-132, 2004.
DOI : 10.1038/nrc1276

M. Cavey, M. Rauzi, P. F. Lenne, and T. Lecuit, A two-tiered mechanism for stabilization and immobilization of E-cadherin, Nature, vol.200, issue.7196, pp.751-756, 2008.
DOI : 10.1038/nature06953

URL : https://hal.archives-ouvertes.fr/hal-00428936

J. M. Chan, M. J. Stampfer, E. Giovannucci, P. H. Gann, J. Ma et al., Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study, Science, vol.279, issue.5350, pp.563-566, 1998.
DOI : 10.1126/science.279.5350.563

X. Chen, J. M. Corbin, G. J. Tipton, L. V. Yang, A. S. Asch et al., The TMEFF2 tumor suppressor modulates integrin expression, RhoA activation and migration of prostate cancer cells, Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, vol.1843, issue.6, pp.1216-1224, 2014.
DOI : 10.1016/j.bbamcr.2014.03.005

X. Q. Chen, I. Tan, C. H. Ng, C. Hall, L. Lim et al., Characterization of RhoA-binding Kinase ROK?? Implication of the Pleckstrin Homology Domain in ROK?? Function Using Region-specific Antibodies, Journal of Biological Chemistry, vol.277, issue.15, pp.12680-12688, 2002.
DOI : 10.1074/jbc.M109839200

L. Cheng, S. Zhang, C. J. Sweeney, C. Kao, T. A. Gardner et al., Androgen withdrawal inhibits tumor growth and is associated with decrease in angiogenesis and VEGF expression in androgen-independent CWR22Rv1 human prostate cancer model, Anticancer Res, vol.24, issue.4, pp.2135-2140, 2004.

V. Chevrier, M. Piel, N. Collomb, Y. Saoudi, R. Frank et al., The Rho-associated protein kinase p160ROCK is required for centrosome positioning, The Journal of Cell Biology, vol.65, issue.5, pp.807-817, 2002.
DOI : 10.1038/40187

F. K. Sesterhenn, T. R. Mostofi, M. P. Fears, R. G. Madigan, J. F. Ziegler et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China, Cancer Epidemiol Biomarkers Prev, vol.10, issue.5, pp.421-427, 2001.

R. Serre, P. Bouvier, F. Clezardin, and . Cabon, Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate, Cancer Res, vol.65, issue.1, pp.300-308, 2005.

H. R. Contreras, R. A. Ledezma, J. Vergara, F. Cifuentes, C. Barra et al., The expression of syndecan-1 and -2 is associated with Gleason score and epithelial-mesenchymal transition markers, E-cadherin and ??-catenin, in prostate cancer, Urologic Oncology: Seminars and Original Investigations, vol.28, issue.5, pp.534-540, 2010.
DOI : 10.1016/j.urolonc.2009.03.018

L. M. Coussens, B. Fingleton, and L. M. Matrisian, Matrix Metalloproteinase Inhibitors and Cancer--Trials and Tribulations, Science, vol.295, issue.5564, pp.2387-2392, 2002.
DOI : 10.1126/science.1067100

D. Cvetkovic, B. Movsas, A. P. Dicker, A. L. Hanlon, R. E. Greenberg et al., Increased hypoxia correlates with increased expression of the angiogenesis marker vascular endothelial growth factor in human prostate cancer, Urology, vol.57, issue.4, pp.821-825, 2001.
DOI : 10.1016/S0090-4295(00)01044-X

F. Daneshgari and E. D. Crawford, Endocrine therapy of advanced carcinoma of the prostate, Cancer, vol.146, issue.3, pp.1089-1097, 1993.
DOI : 10.1002/1097-0142(19930201)71:3+<1089::AID-CNCR2820711431>3.0.CO;2-H

G. Davies, M. D. Mason, T. A. Martin, C. Parr, G. Watkins et al., The HGF/SF antagonist NK4 reverses fibroblast- and HGF-induced prostate tumor growth and angiogenesisin vivo, International Journal of Cancer, vol.61, issue.3, pp.348-354, 2003.
DOI : 10.1002/ijc.11220

M. Biglioli, M. C. Napolitano, M. Capogrossi, and . Pesce, SDF-1 involvement in endothelial phenotype and ischemia-induced recruitment of bone marrow progenitor cells, Blood, vol.104, issue.12, pp.3472-3482, 2004.

D. Palma, M. , C. Murdoch, M. A. Venneri, L. Naldini et al., Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications, Trends in Immunology, vol.28, issue.12, pp.519-524, 2007.
DOI : 10.1016/j.it.2007.09.004

D. Palma, M. , M. A. Venneri, R. Galli, L. Sergi-sergi et al., Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors, Cancer Cell, vol.8, issue.3, pp.211-226, 2005.
DOI : 10.1016/j.ccr.2005.08.002

N. B. Delongchamps, F. Beuvon, J. R. Mathieu, S. Delmas, I. Metzger et al., CXCR4 is highly expressed at the tumor front but not in the center of prostate cancers, World Journal of Urology, vol.25, issue.2, 2014.
DOI : 10.1007/s00345-014-1299-0

S. M. Dudek and J. G. Garcia, Cytoskeletal regulation of pulmonary vascular permeability, J Appl Physiol, vol.91, issue.4, pp.1487-1500, 1985.

S. Duong-quy, Y. Bei, Z. Liu, and A. T. Dinh-xuan, Role of Rho-kinase and its inhibitors in pulmonary hypertension, Pharmacology & Therapeutics, vol.137, issue.3, pp.352-364, 2013.
DOI : 10.1016/j.pharmthera.2012.12.003

J. L. Duque, K. R. Loughlin, R. M. Adam, P. W. Kantoff, D. Zurakowski et al., Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer, Urology, vol.54, issue.3, pp.523-527, 1999.
DOI : 10.1016/S0090-4295(99)00167-3

J. M. Ebos, C. R. Lee, W. Cruz-munoz, G. A. Bjarnason, J. G. Christensen et al., Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis, Cancer Cell, vol.15, issue.3, pp.232-239, 2009.
DOI : 10.1016/j.ccr.2009.01.021

J. I. Epstein, Can insignificant prostate cancer be predicted preoperatively in men with stage T1 disease?, Semin Urol Oncol, vol.14, issue.3, pp.165-173, 1996.

J. Vizoso, Study of matrix metalloproteinases and their inhibitors in prostate cancer, Br J Cancer, vol.102, issue.5, pp.922-929, 2010.

S. Etienne-manneville and A. Hall, Rho GTPases in cell biology, Nature, vol.92, issue.6916, pp.629-635, 2002.
DOI : 10.1074/jbc.M108297200

L. Zannetti, P. Thill, and . Beuzeboc, Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study, BJU Int, vol.106, issue.7, pp.974-978, 2010.

R. Farooqui and G. Fenteany, Multiple rows of cells behind an epithelial wound edge extend cryptic lamellipodia to collectively drive cell-sheet movement, Journal of Cell Science, vol.118, issue.1, pp.51-63, 2005.
DOI : 10.1242/jcs.01577

F. A. Ferrer, L. J. Miller, R. I. Andrawis, S. H. Kurtzman, P. C. Albertsen et al., Vascular Endothelial Growth Factor (VEGF) Expression in Human Prostate Cancer, The Journal of Urology, vol.157, issue.6, pp.2329-2333, 1997.
DOI : 10.1097/00005392-199706000-00108

F. A. Ferrer, L. J. Miller, R. I. Andrawis, S. H. Kurtzman, P. C. Albertsen et al., Angiogenesis and Prostate Cancer: In vivo and In vitro Expression of Angiogenesis Factors by Prostate Cancer Cells, Urology, vol.51, issue.1, pp.161-167, 1998.
DOI : 10.1016/S0090-4295(97)00491-3

J. Folkman, P. Cole, and S. Zimmerman, Tumor Behavior in Isolated Perfused Organs, Annals of Surgery, vol.164, issue.3, pp.491-502, 1966.
DOI : 10.1097/00000658-196609000-00012

S. A. Forbes, G. Bhamra, S. Bamford, E. Dawson, C. Kok et al., The Catalogue of Somatic Mutations in Cancer (COSMIC), Curr Protoc Hum Genet Chapter, vol.274, issue.10, p.11, 2008.
DOI : 10.1002/0471142905.hg1011s57

S. A. Forbes, G. Tang, N. Bindal, S. Bamford, E. Dawson et al., COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer, Nucleic Acids Research, vol.38, issue.Database, pp.652-657, 2010.
DOI : 10.1093/nar/gkp995

C. Frantz, T. Coppola, and R. Regazzi, Involvement of Rho GTPases and Their Effectors in the Secretory Process of PC12 Cells, Experimental Cell Research, vol.273, issue.2, pp.119-126, 2002.
DOI : 10.1006/excr.2001.5432

P. Friedl and D. Gilmour, Collective cell migration in morphogenesis, regeneration and cancer, Nature Reviews Molecular Cell Biology, vol.112, issue.7, pp.445-457, 2009.
DOI : 10.1111/j.1524-475X.2006.00191.x

P. Friedl, P. B. Noble, P. A. Walton, D. W. Laird, P. J. Chauvin et al., Migration of coordinated cell clusters in mesenchymal and epithelial cancer explants in vitro, Cancer Res, vol.55, issue.20, pp.4557-4560, 1995.

G. Fritz, C. Brachetti, F. Bahlmann, M. Schmidt, and B. Kaina, Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters, British Journal of Cancer, vol.59, issue.6, pp.635-644, 2002.
DOI : 10.1038/sj.bjc.6600510

R. Fukuda, K. Hirota, F. Fan, Y. D. Jung, L. M. Ellis et al., Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells, Journal of Biological Chemistry, vol.277, issue.41, pp.38205-38211, 2002.
DOI : 10.1074/jbc.M203781200

S. Gasman, S. Chasserot-golaz, P. Hubert, D. Aunis, and M. F. Bader, Identification of a Potential Effector Pathway for the Trimeric Go Protein Associated with Secretory Granules. Go STIMULATES A GRANULE-BOUND PHOSPHATIDYLINOSITOL 4-KINASE BY ACTIVATING RhoA IN CHROMAFFIN CELLS, Journal of Biological Chemistry, vol.273, issue.27, pp.16913-16920, 1998.
DOI : 10.1074/jbc.273.27.16913

. Genecards, Ras Homolog Family Member A. Retrieved from http, 2014.

. Genecards, Rho-Associated, Coiled-Coil Containing Protein Kinase 1. Retrieved from http, 2014.

. Genecards, Rho-Associated, Coiled-Coil Containing Protein Kinase 2. Retrieved from http, 2014.

M. Glotzer, Animal Cell Cytokinesis, Annual Review of Cell and Developmental Biology, vol.17, issue.1, pp.351-386, 2001.
DOI : 10.1146/annurev.cellbio.17.1.351

M. S. Goligorsky, A. S. Budzikowski, H. Tsukahara, and E. Noiri, CO-OPERATION BETWEEN ENDOTHELIN AND NITRIC OXIDE IN PROMOTING ENDOTHELIAL CELL MIGRATION AND ANGIOGENESIS, Clinical and Experimental Pharmacology and Physiology, vol.26, issue.3, pp.269-271, 1999.
DOI : 10.1006/bbrc.1993.1327

D. J. Good, P. J. Polverini, F. Rastinejad, M. M. Le-beau, R. S. Lemons et al., A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin., Proceedings of the National Academy of Sciences, vol.87, issue.17, pp.6624-6628, 1990.
DOI : 10.1073/pnas.87.17.6624

J. Gotzmann, M. Mikula, A. Eger, R. Schulte-hermann, R. Foisner et al., Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis, Mutation Research/Reviews in Mutation Research, vol.566, issue.1, pp.9-20, 2004.
DOI : 10.1016/S1383-5742(03)00033-4

M. Grandoch, A. Rose, M. Ter-braak, V. Jendrossek, H. Rubben et al., Epac inhibits migration and proliferation of human prostate carcinoma cells, British Journal of Cancer, vol.63, issue.12, pp.2038-2042, 2009.
DOI : 10.1152/ajpheart.01317.2007

. Stratford, Expression of vascular endothelial growth factor (VEGF) in locally invasive prostate cancer is prognostic for radiotherapy outcome, Int J Radiat Oncol Biol Phys, vol.67, issue.1, pp.84-90, 2007.

. Stratton, Patterns of somatic mutation in human cancer genomes, European Journal of Cancer Supplements, vol.6, issue.9, pp.153-158, 2007.
DOI : 10.1016/S1359-6349(08)71197-2

F. Grinnell, Fibroblast mechanics in three-dimensional collagen matrices, Journal of Bodywork and Movement Therapies, vol.12, issue.3, pp.191-193, 2008.
DOI : 10.1016/j.jbmt.2008.03.005

G. Heijnsdijk, H. J. Draisma, R. De-koning, and . Etzioni, What if i don't treat my PSA-detected prostate cancer? Answers from three natural history models, Cancer Epidemiol Biomarkers Prev, vol.20, issue.5, pp.740-750, 2011.

S. L. Gupton and F. B. Gertler, Filopodia: The Fingers That Do the Walking, Science's STKE, vol.2007, issue.400, p.5, 2007.
DOI : 10.1126/stke.4002007re5

G. Jumbelic, R. Threatte, H. Korets, G. Lilja, and . De-la-roza, Needle biopsies on autopsy prostates: sensitivity of cancer detection based on true prevalence, J Natl Cancer Inst, vol.99, pp.1484-1489, 2007.

D. Hanahan and J. Folkman, Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis, Cell, vol.86, issue.3, pp.353-364, 1996.
DOI : 10.1016/S0092-8674(00)80108-7

D. Hanahan and R. A. Weinberg, Hallmarks of Cancer: The Next Generation, Cell, vol.144, issue.5, pp.646-674, 2011.
DOI : 10.1016/j.cell.2011.02.013

P. Hao, X. Chen, H. Geng, L. Gu, J. Chen et al., Expression and implication of hypoxia inducible factor-1?? in prostate neoplasm, Journal of Huazhong University of Science and Technology [Medical Sciences], vol.9, issue.6, pp.593-595, 2004.
DOI : 10.1007/BF02911365

M. E. Harper, E. Glynne-jones, L. Goddard, V. J. Thurston, and K. Griffiths, Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells, British Journal of Cancer, vol.74, issue.6, pp.910-916, 1996.
DOI : 10.1038/bjc.1996.456

A. Heidenreich, P. J. Bastian, J. Bellmunt, M. Bolla, S. Joniau et al., EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent???Update 2013, European Urology, vol.65, issue.1, pp.124-137, 2014.
DOI : 10.1016/j.eururo.2013.09.046

K. Hida, Y. Hida, D. N. Amin, A. F. Flint, D. Panigrahy et al., Tumor-Associated Endothelial Cells with Cytogenetic Abnormalities, Cancer Research, vol.64, issue.22, pp.8249-8255, 2004.
DOI : 10.1158/0008-5472.CAN-04-1567

J. C. Hodge, J. Bub, S. Kaul, A. Kajdacsy-balla, and P. F. Lindholm, Requirement of RhoA activity for increased nuclear factor kappaB activity and PC-3 human prostate cancer cell invasion, Cancer Res, vol.63, issue.6, pp.1359-1364, 2003.

S. Horowitz, D. G. Binion, V. M. Nelson, Y. Kanaa, P. Javadi et al., Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease, AJP: Gastrointestinal and Liver Physiology, vol.292, issue.5, pp.1323-1336, 2007.
DOI : 10.1152/ajpgi.00499.2006

K. Hotary, X. Y. Li, E. Allen, S. L. Stevens, and S. J. Weiss, A cancer cell metalloprotease triad regulates the basement membrane transmigration program, Genes & Development, vol.20, issue.19, pp.2673-2686, 2006.
DOI : 10.1101/gad.1451806

M. A. Huber, N. Kraut, and H. Beug, Molecular requirements for epithelial???mesenchymal transition during tumor progression, Current Opinion in Cell Biology, vol.17, issue.5, pp.548-558, 2005.
DOI : 10.1016/j.ceb.2005.08.001

F. Imamura, M. Mukai, M. Ayaki, and H. Akedo, Y-27632, an Inhibitor of Rho-associated Protein Kinase, Suppresses Tumor Cell Invasion via Regulation of Focal Adhesion and Focal Adhesion Kinase, Japanese Journal of Cancer Research, vol.9, issue.8, pp.811-816, 2000.
DOI : 10.1111/j.1349-7006.2000.tb01018.x

K. Inoue, J. W. Slaton, B. Y. Eve, S. J. Kim, P. Perrotte et al., Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer, Clin Cancer Res, vol.6, issue.5, pp.2104-2119, 2000.

T. Isayeva, D. Chanda, L. Kallman, I. E. Eltoum, and S. Ponnazhagan, Effects of Sustained Antiangiogenic Therapy in Multistage Prostate Cancer in TRAMP Model, Cancer Research, vol.67, issue.12, pp.5789-5797, 2007.
DOI : 10.1158/0008-5472.CAN-06-3637

T. Ishiuchi and M. Takeichi, Willin and Par3 cooperatively regulate epithelial apical constriction through aPKC-mediated ROCK phosphorylation, Nature Cell Biology, vol.325, issue.7, pp.860-866, 2011.
DOI : 10.1155/2010/927585

T. Ishizaki, M. Maekawa, K. Fujisawa, K. Okawa, A. Iwamatsu et al., The small GTP-binding protein Rho binds to and activates a 160 kDa Ser/Thr protein kinase homologous to myotonic dystrophy kinase, EMBO J, vol.15, issue.8, pp.1885-1893, 1996.

K. Itoh, K. Yoshioka, H. Akedo, M. Uehata, T. Ishizaki et al., An essential part for Rho-associated kinase in the transcellular invasion of tumor cells, Nature Medicine, vol.5, issue.2, pp.221-225, 1999.
DOI : 10.1038/5587

I. Izawa, M. Amano, K. Chihara, T. Yamamoto, and K. Kaibuchi, Possible involvement of the inactivation of the Rho-Rho-kinase pathway in oncogenic Ras-induced transformation, Oncogene, vol.17, issue.22, pp.2863-2871, 1998.
DOI : 10.1038/sj.onc.1202213

M. W. Jackson, J. M. Bentel, and W. D. Tilley, Vascular Endothelial Growth Factor (VEGF) Expression in Prostate Cancer and Benign Prostatic Hyperplasia, The Journal of Urology, vol.157, issue.6, pp.2323-2328, 1997.
DOI : 10.1016/S0022-5347(01)64774-8

B. Jimenez, O. V. Volpert, S. E. Crawford, M. Febbraio, R. L. Silverstein et al., Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1, Nature Medicine, vol.16, issue.1, pp.41-48, 2000.
DOI : 10.1074/jbc.274.27.19055

T. Kamai, K. Arai, S. Sumi, T. Tsujii, M. Honda et al., The rho/rho-kinase pathway is involved in the progression of testicular germ cell tumour, BJU International, vol.15, issue.4, pp.449-453, 2002.
DOI : 10.1046/j.1464-4096.2001.01920.x

T. Kamai, T. Tsujii, K. Arai, K. Takagi, H. Asami et al., Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer, Clin Cancer Res, vol.9, issue.7, pp.2632-2641, 2003.

P. J. Kaplan, S. Mohan, P. Cohen, B. A. Foster, and N. M. Greenberg, The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model, Cancer Res, vol.59, issue.9, pp.2203-2209, 1999.

S. Kellouche, S. Mourah, A. Bonnefoy, D. Schoevaert, M. P. Podgorniak et al., Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation, Experimental Cell Research, vol.313, issue.3, pp.486-499, 2007.
DOI : 10.1016/j.yexcr.2006.10.023

J. P. Kantoff, E. Monk, N. J. Kaplan, E. J. Vogelzang, and . Small, Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401, J Clin Oncol, vol.30, issue.13, pp.1534-1540, 2012.

S. S. Kher and R. A. Worthylake, Regulation of ROCKII membrane localization through its C-terminus, Experimental Cell Research, vol.317, issue.20, pp.2845-2852, 2011.
DOI : 10.1016/j.yexcr.2011.09.009

S. J. Kim, H. Uehara, T. Karashima, M. Mccarty, N. Shih et al., Expression of Interleukin-8 Correlates with Angiogenesis, Tumorigenicity, and Metastasis of Human Prostate Cancer Cells Implanted Orthotopically in Nude Mice, Neoplasia, vol.3, issue.1, pp.33-42, 2001.
DOI : 10.1038/sj.neo.7900124

. Kaibuchi, Regulation of the association of adducin with actin filaments by Rho-associated kinase (Rho-kinase) and myosin phosphatase, J Biol Chem, vol.273, issue.10, pp.5542-5548, 1998.

W. B. Kiosses, R. H. Daniels, C. Otey, G. M. Bokoch, and M. A. Schwartz, A Role for P21-Activated Kinase in Endothelial Cell Migration, The Journal of Cell Biology, vol.18, issue.4, pp.831-844, 1999.
DOI : 10.1074/jbc.270.41.23934

E. S. Kopetz, J. B. Nelson, and M. A. Carducci, Endothelin-1 as a target for therapeutic intervention in prostate cancer, Investigational New Drugs, vol.20, issue.2, pp.173-182, 2002.
DOI : 10.1023/A:1015630513908

B. L. Krock, N. Skuli, and M. C. Simon, Hypoxia-Induced Angiogenesis: Good and Evil, Genes & Cancer, vol.2, issue.12, pp.1117-1133, 2011.
DOI : 10.1177/1947601911423654

K. Kurokawa and M. Matsuda, Localized RhoA Activation as a Requirement for the Induction of Membrane Ruffling, Molecular Biology of the Cell, vol.16, issue.9, pp.4294-4303, 2005.
DOI : 10.1091/mbc.E04-12-1076

B. Kwabi-addo, M. Ozen, and M. Ittmann, The role of fibroblast growth factors and their receptors in prostate cancer, Endocrine Related Cancer, vol.11, issue.4, pp.709-724, 2004.
DOI : 10.1677/erc.1.00535

C. Kwak, R. J. Jin, C. Lee, M. S. Park, and S. E. Lee, Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia, BJU International, vol.53, issue.3, pp.303-309, 2002.
DOI : 10.1046/j.1464-4096.2001.01417.x

J. Lane, T. A. Martin, G. Watkins, R. E. Mansel, and W. G. Jiang, The expression and prognostic value of ROCK I and ROCK II and their role in human breast cancer, International Journal of Oncology, vol.33, issue.3, pp.585-593, 2008.
DOI : 10.3892/ijo_00000044

P. N. Lara, P. Jr, D. I. Twardowski, and . Quinn, Angiogenesis-Targeted Therapies in Prostate Cancer, Clinical Prostate Cancer, vol.3, issue.3, pp.165-173, 2004.
DOI : 10.3816/CGC.2004.n.027

T. Leung, E. Manser, L. Tan, and L. Lim, A novel serine/threonine kinase binding the Ras-related RhoA GTPase which translocates the kinase to peripheral membranes, J Biol Chem, vol.270, issue.49, pp.29051-29054, 1995.

Y. Li and P. J. Cozzi, Angiogenesis as a strategic target for prostate cancer therapy, Medicinal Research Reviews, vol.18, issue.1, pp.23-66, 2010.
DOI : 10.1002/med.20161

R. D. Loberg, K. Tantivejkul, M. Craig, C. K. Neeley, and K. J. Pienta, PAR1-mediated RhoA activation facilitates CCL2-induced chemotaxis in PC-3 cells, Journal of Cellular Biochemistry, vol.20, issue.5, pp.1292-1300, 2007.
DOI : 10.1002/jcb.21252

. Oldfield, von Hippel-Lindau disease, Lancet, vol.361, issue.9374, pp.2059-2067, 2003.

M. Hahn and G. Danuser, Coordination of Rho GTPase activities during cell protrusion, Nature, vol.461, issue.7260, pp.99-103, 2009.

D. J. Manalo, A. Rowan, T. Lavoie, L. Natarajan, B. D. Kelly et al., Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1, Blood, vol.105, issue.2, pp.659-669, 2005.
DOI : 10.1182/blood-2004-07-2958

T. Matsui, M. Amano, T. Yamamoto, K. Chihara, M. Nakafuku et al., Rho-associated kinase, a novel serine/threonine kinase, as a putative target for small GTP binding protein Rho, EMBO J, vol.15, issue.9, pp.2208-2216, 1996.

T. Matsui, M. Maeda, Y. Doi, S. Yonemura, M. Amano et al., Rho-Kinase Phosphorylates COOH-terminal Threonines of Ezrin/Radixin/Moesin (ERM) Proteins and Regulates Their Head-to-Tail Association, The Journal of Cell Biology, vol.268, issue.3, pp.647-657, 1998.
DOI : 10.1083/jcb.120.2.437

D. Mehta and A. B. Malik, Signaling Mechanisms Regulating Endothelial Permeability, Physiological Reviews, vol.86, issue.1, pp.279-367, 2006.
DOI : 10.1152/physrev.00012.2005

S. Ruffieux, J. P. Rusconi, Z. Montani, and . Yang, Thrombin stimulates human endothelial arginase enzymatic activity via RhoA/ROCK pathway: implications for atherosclerotic endothelial dysfunction, Circulation, vol.110, issue.24, pp.3708-3714, 2004.

R. Montesano, L. Orci, and P. Vassalli, In vitro rapid organization of endothelial cells into capillary-like networks is promoted by collagen matrices, The Journal of Cell Biology, vol.97, issue.5, pp.1648-1652, 1983.
DOI : 10.1083/jcb.97.5.1648

M. Morgan-fisher, U. M. Wewer, and A. Yoneda, Regulation of ROCK Activity in Cancer, Journal of Histochemistry & Cytochemistry, vol.32, issue.3, pp.185-198, 2013.
DOI : 10.1038/nbt1210-1248

C. Murphy, M. Mcgurk, J. Pettigrew, A. Santinelli, R. Mazzucchelli et al., Nonapical and Cytoplasmic Expression of Interleukin-8, CXCR1, and CXCR2 Correlates with Cell Proliferation and Microvessel Density in Prostate Cancer, Clinical Cancer Research, vol.11, issue.11, pp.4117-4127, 2005.
DOI : 10.1158/1078-0432.CCR-04-1518

S. Narumiya, M. Tanji, and T. Ishizaki, Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion, Cancer and Metastasis Reviews, vol.120, issue.1-2, pp.65-76, 2009.
DOI : 10.1007/s10555-008-9170-7

A. C. Newman, M. N. Nakatsu, W. Chou, P. D. Gershon, and C. C. Hughes, The requirement for fibroblasts in angiogenesis: fibroblast-derived matrix proteins are essential for endothelial cell lumen formation, Molecular Biology of the Cell, vol.22, issue.20, pp.3791-3800, 2011.
DOI : 10.1091/mbc.E11-05-0393

. Campbell, Cannabinoid receptor type 1 (CB1) activation inhibits small GTPase RhoA activity and regulates motility of prostate carcinoma cells, Endocrinology, vol.153, issue.1, pp.29-41, 2012.

M. Olson and E. Sahai, The actin cytoskeleton in cancer cell motility, Clinical & Experimental Metastasis, vol.9, issue.Pt 3, pp.273-287, 2009.
DOI : 10.1007/s10585-008-9174-2

M. Paez-ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Cancer Cell, vol.15, issue.3, pp.220-231, 2009.
DOI : 10.1016/j.ccr.2009.01.027

G. Pawlak and D. M. Helfman, Post-transcriptional Down-regulation of ROCKI/Rho-kinase through an MEK-dependent Pathway Leads to Cytoskeleton Disruption in Ras-transformed Fibroblasts, Molecular Biology of the Cell, vol.13, issue.1, pp.336-347, 2002.
DOI : 10.1091/mbc.01-06-0302

O. Pertz, L. Hodgson, R. L. Klemke, and K. M. Hahn, Spatiotemporal dynamics of RhoA activity in migrating cells, Nature, vol.406, issue.7087, pp.1069-1072, 2006.
DOI : 10.1038/nature04665

I. Petrache, M. T. Crow, M. Neuss, and J. G. Garcia, Central involvement of Rho family GTPases in TNF-alpha-mediated bovine pulmonary endothelial cell apoptosis, 2003.

M. Peyromaure, P. Camparo, C. Badoual, A. Descazeaud, and A. T. Dinh-xuan, The expression of vascular endothelial growth factor is associated with the risk of cancer progression after radical prostatectomy, BJU International, vol.22, issue.5, pp.1150-1153, 2007.
DOI : 10.1016/S0302-2838(02)00276-2

M. Peyromaure, B. Debre, K. Mao, G. Zhang, Y. Wang et al., MANAGEMENT OF PROSTATE CANCER IN CHINA: A MULTICENTER REPORT OF 6 INSTITUTIONS, The Journal of Urology, vol.174, issue.5, pp.1794-1797, 2005.
DOI : 10.1097/01.ju.0000176817.46279.93

A. Pezzolo, F. Parodi, M. V. Corrias, R. Cinti, C. Gambini et al., Tumor Origin of Endothelial Cells in Human Neuroblastoma, Journal of Clinical Oncology, vol.25, issue.4, pp.376-383, 2007.
DOI : 10.1200/JCO.2006.09.0696

C. Vannier, C. Malvy, H. Soria, and . Li, Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo, Mol Ther, vol.11, issue.2, pp.267-274, 2005.

R. L. Morrissey, B. S. Vessella, and . Knudsen, Metastatic progression of prostate cancer and e-cadherin regulation by zeb1 and SRC family kinases, Am J Pathol, vol.179, issue.1, pp.400-410, 2011.

K. Riento and A. J. Ridley, Rocks: multifunctional kinases in cell behaviour, Nature Reviews Molecular Cell Biology, vol.4, issue.6, pp.446-456, 2003.
DOI : 10.1038/nrm1128

K. A. Roehl, M. Han, C. G. Ramos, J. A. Antenor, and W. J. Catalona, CANCER PROGRESSION AND SURVIVAL RATES FOLLOWING ANATOMICAL RADICAL RETROPUBIC PROSTATECTOMY IN 3,478 CONSECUTIVE PATIENTS: LONG-TERM RESULTS, The Journal of Urology, vol.172, issue.3, pp.910-914, 2004.
DOI : 10.1097/01.ju.0000134888.22332.bb

D. Rosel, J. Brabek, O. Tolde, C. T. Mierke, D. P. Zitterbart et al., Up-Regulation of Rho/ROCK Signaling in Sarcoma Cells Drives Invasion and Increased Generation of Protrusive Forces, Molecular Cancer Research, vol.6, issue.9, pp.1410-1420, 2008.
DOI : 10.1158/1541-7786.MCR-07-2174

P. J. Russell, S. Bennett, and P. Stricker, Growth factor involvement in progression of prostate cancer, Clin Chem, vol.44, issue.4, pp.705-723, 1998.

E. Sahai, Illuminating the metastatic process, Nature Reviews Cancer, vol.23, issue.10, pp.737-749, 2007.
DOI : 10.1038/nrc2229

E. Sahai and C. J. Marshall, RHO???GTPASES AND CANCER, Nature Reviews Cancer, vol.5, issue.2, pp.133-142, 2002.
DOI : 10.1002/1097-0215(20001101)88:3<369::AID-IJC8>3.0.CO;2-K

S. Sakamoto, A. J. Ryan, and N. Kyprianou, Targeting vasculature in urologic tumors: Mechanistic and therapeutic significance, Journal of Cellular Biochemistry, vol.349, issue.3, pp.691-708, 2008.
DOI : 10.1002/jcb.21442

D. and P. Chavrier, The interaction of IQGAP1 with the exocyst complex is required for tumor cell invasion downstream of Cdc42 and RhoA, J Cell Biol, vol.181, issue.6, pp.985-998, 2008.

D. Salani, G. Taraboletti, L. Rosano, V. D. Castro, P. Borsotti et al., Endothelin-1 Induces an Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo, The American Journal of Pathology, vol.157, issue.5, pp.1703-1711, 2000.
DOI : 10.1016/S0002-9440(10)64807-9

M. Weaver and M. F. Olson, Actomyosin-mediated cellular tension drives increased tissue stiffness and beta-catenin activation to induce epidermal hyperplasia and tumor growth, Cancer Cell, vol.19, issue.6, pp.776-791, 2011.

A. D. Santin, P. L. Hermonat, A. Ravaggi, M. J. Cannon, S. Pecorelli et al., Secretion of vascular endothelial growth factor in ovarian cancer, Eur J Gynaecol Oncol, vol.20, issue.3, pp.177-181, 1999.

A. V. Schofield and O. Bernard, Rho-associated coiled-coil kinase (ROCK) signaling and disease, Critical Reviews in Biochemistry and Molecular Biology, vol.30, issue.4, pp.301-316, 2013.
DOI : 10.3748/wjg.v9.i1.9

G. Bangma, A. Aus, X. Villers, T. Rebillard, B. G. Van-der-kwast et al., Screening and prostate-cancer mortality in a randomized European study, N Engl J Med, vol.360, issue.13, pp.1320-1328, 2009.

N. Sharma, R. E. Seftor, E. A. Seftor, L. M. Gruman, P. M. Heidger et al., Prostatic tumor cell plasticity involves cooperative interactions of distinct phenotypic subpopulations: Role in vasculogenic mimicry, The Prostate, vol.14, issue.3, pp.189-201, 2002.
DOI : 10.1002/pros.10048

S. Moss, L. A. , S. Jensen-taubman, and W. G. Stetler-stevenson, Matrix Metalloproteinases, The American Journal of Pathology, vol.181, issue.6, pp.1895-1899, 2012.
DOI : 10.1016/j.ajpath.2012.08.044

R. Siegel, D. Naishadham, and A. , Cancer statistics, 2013, Cancer statistics, pp.11-30, 2013.
DOI : 10.3322/caac.21166

W. C. Sin, X. Q. Chen, T. Leung, and L. Lim, RhoA-Binding Kinase ?? Translocation Is Facilitated by the Collapse of the Vimentin Intermediate Filament Network, Molecular and Cellular Biology, vol.18, issue.11, pp.6325-6339, 1998.
DOI : 10.1128/MCB.18.11.6325

E. Sivridis, A. Giatromanolaki, I. Papadopoulos, K. C. Gatter, A. L. Harris et al., Thymidine phosphorylase expression in normal, hyperplastic and neoplastic prostates: correlation with tumour associated macrophages, infiltrating lymphocytes, and angiogenesis, British Journal of Cancer, vol.91, issue.9, pp.1465-1471, 2002.
DOI : 10.1038/sj.bjc.6600281

A. L. Smith, M. R. Dohn, M. V. Brown, and A. B. Reynolds, Association of Rho-associated protein kinase 1 with E-cadherin complexes is mediated by p120-catenin, Molecular Biology of the Cell, vol.23, issue.1, pp.99-110, 2012.
DOI : 10.1091/mbc.E11-06-0497

A. P. Somlyo and A. V. Somlyo, Ca2+ Sensitivity of Smooth Muscle and Nonmuscle Myosin II: Modulated by G Proteins, Kinases, and Myosin Phosphatase, Physiological Reviews, vol.83, issue.4, pp.1325-1358, 2003.
DOI : 10.1152/physrev.00023.2003

A. V. Somlyo, C. Phelps, C. Dipierro, M. Eto, P. Read et al., Rho kinase and matrix metalloproteinase inhibitors cooperate to inhibit angiogenesis and growth of human prostate cancer xenotransplants, The FASEB Journal, vol.17, issue.2, pp.223-234, 2003.
DOI : 10.1096/fj.02-0655com

G. Roobol, P. Steineck, and . Wiklund, Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes, BMJ, vol.348, p.1502, 2014.

D. Spiering and L. Hodgson, Dynamics of the Rho-family small GTPases in actin regulation and motility, Cell Adhesion & Migration, vol.14, issue.2, pp.170-180, 2011.
DOI : 10.1128/MCB.22.18.6582-6591.2002

T. A. Stamey, C. M. Yemoto, J. E. Mcneal, B. M. Sigal, and I. M. Johnstone, PROSTATE CANCER IS HIGHLY PREDICTABLE: A PROGNOSTIC EQUATION BASED ON ALL MORPHOLOGICAL VARIABLES IN RADICAL PROSTATECTOMY SPECIMENS, The Journal of Urology, vol.163, issue.4, pp.1155-1160, 2000.
DOI : 10.1016/S0022-5347(05)67713-0

D. Stefanou, A. Batistatou, S. Kamina, E. Arkoumani, D. J. Papachristou et al., Expression of vascular endothelial growth factor (VEGF) and association with microvessel density in benign prostatic hyperplasia and prostate cancer, In Vivo, vol.18, issue.2, pp.155-160, 2004.

A. P. Struckhoff, M. K. Rana, and R. A. Worthylake, RhoA can lead the way in tumor cell invasion and metastasis, Frontiers in Bioscience, vol.16, issue.1, pp.1915-1926, 2011.
DOI : 10.2741/3830

H. Sun, J. W. Breslin, J. Zhu, S. Y. Yuan, and M. H. Wu, Rho and ROCK Signaling in VEGF-Induced Microvascular Endothelial Hyperpermeability, Microcirculation, vol.272, issue.3, pp.237-247, 2006.
DOI : 10.1080/10739680600556944

E. Reiter, Monoclonal antibody targeting of N-cadherin inhibits prostate cancer growth, metastasis and castration resistance, Nat Med, vol.16, issue.12, pp.1414-1420, 2010.

K. Tomita, A. Van-bokhoven, G. J. Van-leenders, E. T. Ruijter, C. F. Jansen et al., Cadherin switching in human prostate cancer progression, Cancer Res, vol.60, issue.13, pp.3650-3654, 2000.

L. Trojan, D. Thomas, T. Knoll, R. Grobholz, P. Alken et al., Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer, Urol Res, vol.32, issue.2, pp.97-103, 2004.

R. Umbas, W. B. Isaacs, P. P. Bringuier, H. E. Schaafsma, H. F. Karthaus et al., Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer, Cancer Res, vol.54, issue.14, pp.3929-3933, 1994.

F. Valderrama and A. J. Ridley, Getting invasive with GEP100 and Arf6, Nature Cell Biology, vol.2003, issue.1, pp.16-18, 2008.
DOI : 10.1016/j.tcb.2007.01.002

L. Van-aelst and C. D. Souza-schorey, Rho GTPases and signaling networks, Genes & Development, vol.11, issue.18, pp.2295-2322, 1997.
DOI : 10.1101/gad.11.18.2295

G. P. Van-nieuw-amerongen, Involvement of RhoA/Rho Kinase Signaling in VEGF-Induced Endothelial Cell Migration and Angiogenesis In Vitro, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.23, issue.2, pp.211-217, 2002.
DOI : 10.1161/01.ATV.0000054198.68894.88

F. M. Vega and A. J. Ridley, Rho GTPases in cancer cell biology, FEBS Letters, vol.6, issue.14, pp.2093-2101, 2008.
DOI : 10.1016/j.febslet.2008.04.039

D. Vignjevic and G. Montagnac, Reorganisation of the dendritic actin network during cancer cell migration and invasion, Seminars in Cancer Biology, vol.18, issue.1, pp.12-22, 2008.
DOI : 10.1016/j.semcancer.2007.08.001

R. Vishnubhotla, S. Sun, J. Huq, M. Bulic, A. Ramesh et al., ROCK-II mediates colon cancer invasion via regulation of MMP-2 and MMP-13 at the site of invadopodia as revealed by multiphoton imaging, Laboratory Investigation, vol.1754, issue.11, pp.1149-1158, 2007.
DOI : 10.1083/jcb.200305010

W. Wang, R. Eddy, and J. Condeelis, The cofilin pathway in breast cancer invasion and metastasis, Nature Reviews Cancer, vol.24, issue.6, pp.429-440, 2007.
DOI : 10.1038/nrc2148

N. Weidner, P. R. Carroll, J. Flax, W. Blumenfeld, and J. Folkman, Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma, Am J Pathol, vol.143, issue.2, pp.401-409, 1993.

K. Wennerberg, K. L. Rossman, and C. J. Der, The Ras superfamily at a glance, Journal of Cell Science, vol.118, issue.5, pp.843-846, 2005.
DOI : 10.1242/jcs.01660

P. Wikstrom, J. Damber, and A. Bergh, Role of transforming growth factor-?1 in prostate cancer, Microscopy Research and Technique, vol.52, issue.4, pp.411-419, 2001.
DOI : 10.1002/1097-0029(20010215)52:4<411::AID-JEMT1026>3.0.CO;2-8

K. Woodson, J. A. Tangrea, M. Pollak, T. D. Copeland, P. R. Taylor et al., Serum insulin-like growth factor I: tumor marker or etiologic factor? A prospective study of prostate cancer among Finnish men, Cancer Res, vol.63, issue.14, pp.3991-3994, 2003.

J. L. Wozney and E. S. Antonarakis, Growth factor and signaling pathways and their relevance to prostate cancer therapeutics, Cancer and Metastasis Reviews, vol.66, issue.3, 2014.
DOI : 10.1007/s10555-013-9475-z

F. Y. Wu, S. E. Wang, M. E. Sanders, I. Shin, F. Rojo et al., Reduction of Cytosolic p27Kip1 Inhibits Cancer Cell Motility, Survival, and Tumorigenicity, Cancer Research, vol.66, issue.4, pp.2162-2172, 2006.
DOI : 10.1158/0008-5472.CAN-05-3304

Y. Wu, L. He, L. Zhang, J. Chen, Z. Yi et al., Anacardic Acid (6-Pentadecylsalicylic Acid) Inhibits Tumor Angiogenesis by Targeting Src/FAK/Rho GTPases Signaling Pathway, Journal of Pharmacology and Experimental Therapeutics, vol.339, issue.2, pp.403-411, 2011.
DOI : 10.1124/jpet.111.181891

J. B. Wyckoff, S. E. Pinner, S. Gschmeissner, J. S. Condeelis, and E. Sahai, ROCK- and Myosin-Dependent Matrix Deformation Enables Protease-Independent Tumor-Cell Invasion In Vivo, Current Biology, vol.16, issue.15, pp.1515-1523, 2006.
DOI : 10.1016/j.cub.2006.05.065

K. Kawagoe, H. Takahashi, and . Kurachi, Fasudil inhibits vascular endothelial growth factor-induced angiogenesis in vitro and in vivo, Mol Cancer Ther, vol.6, issue.5, p.117, 2007.

K. Yoshioka, S. Nakamori, and K. Itoh, Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells, Cancer Res, vol.59, issue.8, pp.2004-2010, 1999.

F. Zhang, J. Lee, S. Lu, C. A. Pettaway, and Z. Dong, Blockade of Transforming Growth Factor-?? Signaling Suppresses Progression of Androgen-Independent Human Prostate Cancer in Nude Mice, Clinical Cancer Research, vol.11, issue.12, pp.4512-4520, 2005.
DOI : 10.1158/1078-0432.CCR-04-2571

L. Zhao, G. Xu, J. Zhou, H. Xing, S. Wang et al., The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro, Oncology Reports, vol.15, issue.5, pp.1147-1152, 2006.
DOI : 10.3892/or.15.5.1147

M. Nanus, Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase, Oncogene, vol.25, issue.44, pp.5942-5952, 2006.

H. Zhong, G. L. Semenza, J. W. Simons, and A. M. De-marzo, Up-regulation of hypoxia-inducible factor 1?? is an early event in prostate carcinogenesis, Cancer Detection and Prevention, vol.28, issue.2, pp.88-93, 2004.
DOI : 10.1016/j.cdp.2003.12.009

C. Zhou, M. T. Ling, T. Kin-wah-lee, K. Man, X. Wang et al., FTY720, a fungus metabolite, inhibits invasion ability of androgen-independent prostate cancer cells through inactivation of RhoA-GTPase, Cancer Letters, vol.233, issue.1, pp.36-47, 2006.
DOI : 10.1016/j.canlet.2005.02.039

X. Zhu and P. A. Humphrey, Overexpression and regulation of expression of scatter factor/hepatocyte growth factor in prostatic carcinoma, Urology, vol.56, issue.6, pp.1071-1074, 2000.
DOI : 10.1016/S0090-4295(00)00795-0